Is Trump’s most-favoured-nation drug policy keeping medicine from Canada? Evidence is mixed
MFN deals force drug companies to lower prices in the U.S. by raising them in other countries
See all — The Globe and Mail →Aggregated from the leading newsrooms of the country. Every story links to its original source.







